scanX
Home
Roopa Industries

Roopa Industries

68.99
+3.44
(5.25%)
Market Cap
51.60 Cr
EPS
1.93
PE Ratio
26.10
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
114.90
52 Week low
46.36
PB Ratio
3.31
Debt to Equity
1.52
Add Ratio
Live Chart

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
 1,643.75 4,00,521.00 33.42 49,887.20 12.06 9,648 13.77 33.47
Divis Laboratories
 5,757.05 1,58,705.10 73.83 8,184.00 0.89 1,600 64.53 44.68
Cipla
 1,475.75 1,19,502.60 23.86 26,520.70 14.17 4,155 47.38 53.61
Torrent Pharmaceuticals
 3,039.35 1,04,781.00 55.18 10,785.70 11.59 1,656 13.54 40.36
Dr Reddys Laboratories
 1,151.80 97,705.30 17.90 28,905.40 12.36 5,578 1.69 29.40
Mankind Pharma
 2,327.75 96,889.30 47.03 10,615.60 19.57 1,942 -16.38 37.28
Zydus Life Science
 885.35 90,525.80 19.64 19,831.50 13.82 3,831 29.92 36.58
Lupin
 1,905.35 90,213.10 30.33 20,141.50 19.94 1,936 38.82 33.59
Aurobindo Pharma
 1,115.15 65,122.40 18.38 29,559.20 17.55 3,169 -10.04 40.08
Abbott
 28,941.95 62,536.00 46.09 6,097.20 10.80 1,201 16.01 54.66
Growth Rate
Revenue Growth
-6.77 %
Net Income Growth
15.38 %
Cash Flow Change
-786.49 %
ROE
1.45 %
ROCE
0.71 %
EBITDA Margin (Avg.)
31.64 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
31
34
30
24
30
29
29
51
77
72
115
Expenses
29
32
28
22
28
26
26
48
72
66
108
EBITDA
2
2
3
2
3
3
3
4
5
6
6
Operating Profit %
7 %
-3 %
7 %
-14 %
8 %
6 %
9 %
7 %
5 %
6 %
4 %
Depreciation
1
1
1
1
1
1
1
1
1
1
1
Interest
1
2
2
1
1
1
1
1
2
3
3
Profit Before Tax
0
0
0
0
1
1
1
1
2
2
3
Tax
0
0
0
-0
0
0
0
0
1
1
1
Net Profit
0
0
0
1
1
0
1
1
1
2
2
EPS in ₹
0.20
0.22
0.00
0.69
0.77
0.48
0.98
1.30
1.72
1.93
2.60
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
26
25
29
35
37
38
46
49
57
65
Fixed Assets
8
7
7
6
6
11
10
10
10
9
Current Assets
16
17
22
26
25
27
36
38
42
49
Capital Work in Progress
0
0
0
2
5
0
0
1
1
1
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
18
18
22
27
26
28
36
39
46
55
Total Liabilities
26
25
29
35
37
38
46
49
57
65
Current Liabilities
13
11
11
15
16
19
26
31
39
43
Non Current Liabilities
4
6
8
11
10
9
9
5
3
7
Total Equity
9
9
9
10
10
11
12
13
14
16
Reserve & Surplus
1
1
2
2
3
3
4
5
6
8
Share Capital
8
8
8
8
8
8
8
8
8
8
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
-0
0
0
0
0
1
0
1
Investing Activities
-0
0
-0
3
-2
1
1
4
-1
1
Operating Activities
1
1
-1
-5
4
2
-1
2
-0
-3
Financing Activities
-0
-2
2
2
-2
-3
-1
-5
2
3
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
48.03 %
48.03 %
48.03 %
48.03 %
48.03 %
48.03 %
48.03 %
48.03 %
48.03 %
48.03 %
48.03 %
48.03 %
48.03 %
48.03 %
48.03 %
48.03 %
FIIs
0.00 %
0.00 %
0.00 %
0.25 %
0.25 %
0.25 %
0.25 %
0.25 %
0.25 %
0.25 %
0.25 %
0.25 %
0.25 %
0.25 %
0.25 %
0.25 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.25 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
40.07 %
40.06 %
40.27 %
40.29 %
40.27 %
40.26 %
40.14 %
40.27 %
40.26 %
40.30 %
40.27 %
40.69 %
40.63 %
40.67 %
40.65 %
40.79 %
Others
11.90 %
11.91 %
11.71 %
11.42 %
11.45 %
11.45 %
11.33 %
11.45 %
11.46 %
11.42 %
11.44 %
11.03 %
11.09 %
11.05 %
11.06 %
10.92 %
No of Share Holders
2,863
2,879
2,842
3,075
3,344
3,344
3,535
3,505
3,455
3,513
3,490
3,584
3,622
3,616
3,813
4,005

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Technical Indicators

RSI(14)
Neutral
51.65
ATR(14)
Less Volatile
5.86
STOCH(9,6)
Neutral
26.77
STOCH RSI(14)
Neutral
60.39
MACD(12,26)
Bullish
0.07
ADX(14)
Weak Trend
20.94
UO(9)
Bearish
40.59
ROC(12)
Downtrend But Slowing Down
-4.11
WillR(14)
Neutral
-50.07
Bearish
4
Neutral
4
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Fundamental Screeners
Technical Screeners
Candlestick Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.